E.U. Closes In On Pediatric Drug Patent Extensions
The proposal would grant pharmaceutical companies an additional six months of patent protection if new drugs are tested specifically on children before they are cleared for pediatric use.
Having passed muster in the Brussels-based parliament, the proposal must now be rubber-stamped by the European Council,...
To view the full article, register now.